摘要:
The invention provides methods for generating an antibody specific for the deglycosylated form of a glycopolypeptide using a peptide corresponding to an N-linked glycosylation site of a glycopolypeptide. The invention additionally provides methods for generating an antibody specific for a glycopolypeptide using a peptide corresponding to amino acids adjacent to an authentic N-linked glycosylation site.
摘要:
Methods, compositions, and devices are disclosed which use microRNA to detect, predict, treat, and monitor physiological conditions such as disease or injury. microRNA are isolated and their differential expression is measured to provide diagnostic information. This information may then be utilized for evaluation and/or treatment purposes.
摘要:
The invention provides a method of determining a comparative expression profile in an individual by comparing the expression levels of a sample of molecules in a population of molecules in a specimen from the individual with a health-associated reference expression region of the sample of molecules, wherein expression levels within the health-associated reference expression region indicate a reference expression profile and wherein expression levels outside the health-associated reference expression region indicate a perturbed expression profile. The invention also provides methods of diagnosing a disease or a health state in an individual by comparing the expression level of a sample of molecules in a specimen from the individual with a health-associated reference expression region of the sample of molecules.
摘要:
The invention provides a reagent comprising an affinity tag, a detectable moiety, a linker, an isotope tag and a reactive group. The invention also provides methods of using a reagent of the invention. The methods can be used to label a polypeptide in a sample by contacting a sample with a reagent of the invention under conditions allowing the reactive group to bind to one or more polypeptides in the sample. The invention additionally provides methods of isolating, identifying and quantifying a polypeptide in a sample. The invention further provides methods of diagnosing a disease using a reagent of the invention.
摘要:
The present invention relates to novel prostate specific nucleic acid molecules and polypeptides and related methods for diagnosing or predicting susceptibility to a prostate neoplastic condition.
摘要:
The invention provides an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ (SEQ ID NO:44), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL (SEQ ID NO:45); EGALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQRLNEIDRVNG (SEQ ID NO:46) or MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS (SEQ ID NO:47), or a modification thereof. Also provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:49) or EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:50), or a modification thereof. Further provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ (SEQ ID NO:44) and substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. Methods of using immunomodulatory flagellin peptides additionally are provided.
摘要翻译:本发明提供具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ(SEQ ID NO:44)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节性鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本相同的氨基酸序列TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL(SEQ ID NO:45); 或其修饰物。(SEQ ID NO:46)或MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS(SEQ ID NO:47)或其修饰。 还提供了具有基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本上相同的氨基酸序列TLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:49)或EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:50)或其修饰。 还提供了具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ(SEQ ID NO:44)和基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有类似受体5的氨基酸序列的免疫调节鞭毛蛋白肽 (TLR5)结合。 另外提供了使用免疫调节鞭毛蛋白肽的方法。
摘要:
The invention provides methods of predicting a behavior of a biochemical system. In one embodiment, the method consists of comparing two or more data integration maps of a biochemical system obtained under different conditions, the data integration map comprising at least two networks, and identifying correlative changes in at least two value sets between said two or more data integration maps with different conditions, wherein the correlative changes predict a behavior of the biochemical system.
摘要:
Peptide-major histocompatibility (MHC) Class I nucleic acids and proteins are provided. Methods of their use, for example in methods of identifying antigen-specific T cells and adoptive cell therapy, are also provided.